Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, March 2016

Altmetric Badge

Mentioned by

policy: 1 policy source

Readers on

mendeley: 103 Mendeley

Summary Policy documents

So far, Altmetric has seen 1 policy document that references this research output.

Drugs for Type 2 Diabetes: Second-Line Therapy Review Update

Cited by Canadian Agency for Drugs and Technologies in Health on 28 Nov 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.